Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Journal of the American Medical Informatics Association : JAMIA|October 13, 2017
The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0Anando Sen, Andrew Goldstein, Shreya Chakrabarti, et al.
Neuropsychopharmacology Reports|June 28, 2021
Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label complianceDaniel Fife, Erica A Voss, Jill Hardin, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Assessing Covariate Balance with Small Sample SizesGeorge Hripcsak, Linying Zhang, Yong Chen, et al.
Statistics in Medicine|September 28, 2012
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes PartnershipPatrick B Ryan, David Madigan, Paul E Stang, et al.
Statistics in Medicine|February 16, 2013
Response to comment on 'empirical assessment of methods for risk identification in healthcare data'Patrick B Ryan, David Madigan, Paul E Stang, et al.
Journal of the American Medical Informatics Association : JAMIA|October 17, 2023
Scalable and interpretable alternative to chart review for phenotype evaluation using standardized structured data from electronic health recordsAnna Ostropolets, George Hripcsak, Syed A Husain, et al.
Scientific Data|May 20, 2016
A curated and standardized adverse drug event resource to accelerate drug safety researchJuan M Banda, Lee Evans, Rami S Vanguri, et al.
Drug Safety|October 30, 2013
Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) surveyPaul E Stang, Patrick B Ryan, J Marc Overhage, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 11, 2017
Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort StudyZhong Yuan, Erica A Voss, Frank J DeFalco, et al.
Journal of the American Medical Informatics Association : JAMIA|July 22, 2025
Evaluation of the impact of defining observable time in real-world data on outcome incidenceClair Blacketer, Frank J DeFalco, Mitchell M Conover, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Journal of the American Medical Informatics Association : JAMIA|October 13, 2017
The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0Anando Sen, Andrew Goldstein, Shreya Chakrabarti, et al.
Neuropsychopharmacology Reports|June 28, 2021
Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label complianceDaniel Fife, Erica A Voss, Jill Hardin, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Assessing Covariate Balance with Small Sample SizesGeorge Hripcsak, Linying Zhang, Yong Chen, et al.
Statistics in Medicine|September 28, 2012
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes PartnershipPatrick B Ryan, David Madigan, Paul E Stang, et al.
Statistics in Medicine|February 16, 2013
Response to comment on 'empirical assessment of methods for risk identification in healthcare data'Patrick B Ryan, David Madigan, Paul E Stang, et al.
Journal of the American Medical Informatics Association : JAMIA|October 17, 2023
Scalable and interpretable alternative to chart review for phenotype evaluation using standardized structured data from electronic health recordsAnna Ostropolets, George Hripcsak, Syed A Husain, et al.
Scientific Data|May 20, 2016
A curated and standardized adverse drug event resource to accelerate drug safety researchJuan M Banda, Lee Evans, Rami S Vanguri, et al.
Drug Safety|October 30, 2013
Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) surveyPaul E Stang, Patrick B Ryan, J Marc Overhage, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 11, 2017
Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort StudyZhong Yuan, Erica A Voss, Frank J DeFalco, et al.
Journal of the American Medical Informatics Association : JAMIA|July 22, 2025
Evaluation of the impact of defining observable time in real-world data on outcome incidenceClair Blacketer, Frank J DeFalco, Mitchell M Conover, et al.
Pageof 17